SS Innovations International, Inc. (SSII)
NASDAQ (CM) NASDAQ (CM) Primary 
SS Innovations Submits 510(k) Premarket Notification to the FDA for the Company's SSi Mantra Surgical Robotic System
— Submission covers multiple indications including general, urological, colorectal, gynecological and cardiac surgeries — SS Innovations has officially submitted a 510(k) application to the U.S. FDA for its SSi Mantra surgical robotic system, aiming for clearance to enter the U.S. market.
SS Innovations Announces Successful Completion of First Telesurgery Performed with the Company's SSi Mantra Tele Surgeon Console
Compact New Console Facilitates Performance of Telesurgeries from a Wide Range of Locations, including Physicians' Offices Key Takeaways Historic First for Robotic TelesurgerySS Innovations (Nasdaq: SSII) successfully completed the first telesurgery using its SSi Mantra Tele Surgeon Console (TSC), enabling remote operations from any connected location.
SS Innovations Reports Third Quarter 2025 Financial Results
Quarterly Revenue Increased 192.5% Year over Year to $12.8 Million Driven by Higher SSi Mantra 3 Unit Sales Fort Lauderdale, FL, October 28, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
SS Innovations Provides U.S. Regulatory Update for the SSi Mantra Surgical Robotic System
Company successfully completed a human factors validation study at Johns Hopkins Hospital Anticipates submitting a 510(k) premarket notification to the FDA in the fourth quarter of 2025 Fort Lauderdale, FL, October 2, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
SS Innovations Reports Second Quarter 2025 Financial Results
Record Quarterly Revenue of $10.0 Million Driven by Higher SSi Mantra 3 Unit Sales Gross Profit More than Tripled, Driven by Gross Margin Expansion and Revenue Growth Fort Lauderdale, FL. August 7, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Announces Completion of World's First Intercontinental Robotic Cardiac Telesurgery
Performed by Dr. Sudhir Srivastava utilizing the Company's SSi Mantra 3 surgical robotic system Remotely conducted from IRCAD in Strasbourg, France at an unprecedented distance of more than 4,000 miles to the operating room at SAIMS in Indore, India Fort Lauderdale, FL, July 22, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System
Continuing strong procedure growth, including an upsurge in telesurgeries Fort Lauderdale, FL, July 15, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Announces Completion of World's First Robotic Telesurgery for Weight Loss with the Company's SSi Mantra 3 Surgical Robotic System
Fort Lauderdale, FL, July 10, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations: A Speculative Bet On Robotic Surgeries
SSII is rapidly growing its surgical robotics business, with strong revenue and KPI growth while expanding into new international markets. Despite operating losses and dilution risk, I see a path to profitability as installations and instrument sales accelerate. The stock is aggressively valued, but industry-leading growth and sector hype justify a speculative buy for risk-tolerant investors.
SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System
Surgery performed by Dr. Juan Zuniga at Interhospital in Guayaquil, Ecuador PR Audio: Fort Lauderdale, FL, June 16, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System
FORT LAUDERDALE, Fla., May 27, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Reports First Quarter 2025 Financial Results
Record Quarterly Revenue of $5.1 Million Driven by Higher SSi Mantra 3 Unit Sales On Track for July 2025 De Novo Application to the FDA for SSi Mantra 3 Fort Lauderdale, FL, May 14, 2025 – PRISM MediaWire – SS Innovations International, Inc.
